Nabriva Therapeutics AG (NBRV) insider have most recently took part in a trading activity. On Sep 18, 2017 Vivo Capital Viii, Llc, 10% Owner bought 52,631 shares having total worth of $497,889 at the price of $9.46 per share, following the transaction a total of 4,074,190 shares owned by Vivo Capital Viii, Llc.
The stock has experienced a total of 13 insider trades in the past three months. These trades include 13 sell activities .Furthermore, over the past 12 months , the stock was traded 23 times by insiders. In 23 of these trades, the insider was a seller .
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Nabriva Therapeutics AG (NBRV) traded up 29.3% on Sep 18, 2017, hitting $8.87. 17,084,241 shares of the company’s stock traded hands. Nabriva Therapeutics AG has a 52 week low of $4 and a 52 week high of $12.62. The company’s market cap is $156 million.
Nabriva Therapeutics AG (NBRV) last announced its earnings results on Aug 7, 2017. The company reported -0.54 earnings per share (EPS) for the quarter. The company had revenue of $1 million for the quarter During the same quarter in the previous year, the company posted -9.03 earnings per share. The company’s revenue for the quarter was up 17% on a year-over-year basis.
|earnings per share||-0.54||-5.60||-6.56||0.00||-0.39||-0.17|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018